Background: Cancer has caused nearly 10 million deaths globally in 2020, accounting for one-sixth of all fatalities. Although chemotherapy can be effective in some cases, it often fails to treat solid tumors effectively because of their biological diversity and uncontrolled growth. Chemotherapy can also be toxic, particularly when multiple drugs are used. This study aimed to investigate the potential of combining low-molecular-weight pectin and metformin with chemotherapy in Walker carcinoma cells. Materials and Methods: This study was conducted using white-outbred Wistar rats. Tumors were transplanted subcutaneously, and the animals were then treated with pectin and metformin administered intragastrically using a probe, whereas cytostatic agents were administered intraperitoneally. Antitumor activity was assessed based on three parameters: tumor growth inhibition (TGI), survival/increase in life span (ILS), and average lifespan. Results: The combination of pectin and doxorubicin had the most significant antitumor effect (TGI 88.66% and ILS 142.22%) compared to the combination of metformin and cytostatic agents. In a series of experiments with fluorouracil, a notable antitumor effect was observed with the combination of fluorouracil and metformin (TGI, 89.6%). Conclusion: This study demonstrated that combined therapy with modified citrus pectin and doxorubicin led to higher antitumor effects and ILS than doxorubicin monotherapy. In addition, the combination of metformin and fluorouracil showed the potential to increase survival rates, suggesting its potential detoxifying properties.

Molecular docking, a powerful computational tool, is revolutionizing drug discovery by illuminating the intricate dance between ligands and proteins. This research delves deep into this molecular tango, analyzing how various ligands interact with key disease-linked proteins. The study employed molecular docking to assess the binding affinity and interaction modes of a novel peptide and doxorubicin across diverse target proteins. The peptide emerged as a star performer, exhibiting remarkably strong binding to crucial proteins such as HER3 kinase (−11.906 docking score) and VEGFR (−7.609 docking score). These impressive scores suggest the peptide’s potential as a potent inhibitor for these proteins, potentially disrupting critical cancer pathways. In contrast, doxorubicin displayed significantly weaker binding across all targets, highlighting its potential limitations as an inhibitor. The study further explored the influence of ligand structure and chemical properties on their binding specificity, shedding light on the molecular determinants governing these interactions. By harnessing the power of molecular docking, the research ventured into the exciting realm of rational drug design and virtual screening. Identifying key amino acid residues involved in ligand binding paved the way for designing novel ligands with enhanced binding affinities and improved selectivity profiles. This research paves the way for a deeper understanding of drug-protein interactions at the molecular level, ultimately fostering the development of more effective and targeted therapeutic agents for various diseases.

The capacity of phytosomes to enhance the absorption and bioavailability of bioactive components from plant extracts has made them a notable breakthrough in the fields of dietary supplements and herbal medicine. Using this innovative method, plant extracts are molecularly complexed with phospholipids to produce lipid complexes that resemble cell membrane structures. Because of their structural similarity, these bioactive chemicals are better soluble and absorbed, which makes them easier for the body to use. Pharmaceuticals, nutraceuticals, cosmetics, and functional foods are just a few of the businesses that use phytosomes. Numerous health advantages have resulted from their adaptable use, including protection against antioxidants, improved cognitive function, liver health support, and cardiovascular well-being. However, individual reactions could differ, so exercise caution and seek advice from medical professionals, particularly when used in conjunction with prescription drugs or for particular medical conditions. Phytosomes offer a more effective and efficient way to extract the medicinal qualities of plant extracts, which is a promising development in herbal medicine and nutrition. Their capacity to augment the transportation of bioactive substances presents novel prospects for enhanced health and overall wellbeing, rendering them a remarkable augmentation to the domain of alternative medicines and dietary supplements.

The concept of metabolic regulations deals with the varied and innumerable metabolic pathways that are present in the human body. A combination of such metabolic reactions paves the way to the proper functioning of different physiological and biological processes. Dealing with the adversities of a disease, the engineering of novel metabolic pathways showcases the potential of metabolic engineering and its application in the therapeutic treatment of diseases. A proper and deeper understanding of the metabolic functions in the human body can be known from simulated yeast models. The current review gives a brief understanding of the interactions between the molecular set of metabolomes and their complexity.

Regarding both regional as well as widespread drug delivery, the mucosal and buccal modes of consumption offer a number of benefits. In particular, when a rapid beginning of action must be achieved, they have proven to be an effective rival to the conventional oral approach. Drugs can be easily abused by veins that drain to the elevated and immediately assimilated into circulation throughout the body. In light of this, they are helpful for medicines with high clearance through the liver or digestion in the alimentary canal, as well as for people who have trouble gulping it down. The usual formulation of medications for use with the sublingual and buccal routes is a solid medication. Dosage forms are made of liquid (such as sprays), and dosage forms in a variety of sizes of tablets, wafers, films, patches dose forms that are partially solid (such as gels and drops), and tablets. Standard dosage types include. The biological factors are frequently impacted, which can decrease the formulation’s proximity to the skin. A mucosa could cause unpredictably high medication retention. Numerous things have happened for composition improvements to increase the utilization and retention of medicines in the buccal area and the sublingual area. The physiologic components that will be covered in this primer the development of nanoparticulate delivery systems for drugs, and how it affects buccal and sublingual administration of drugs ways to administering sublingually and buccally therapeutic advancement pathways with compositions that have passed testing for clinical approval will also be covered.

As a recently developing technology, three-dimensional (3D) printing has a lot of potential in the pharmaceutical sector and can cater patients and the pharmaceutical industry with innovative approaches. This technology allows for the accurate creation of dosage forms, which can help with drug product design. It also facilitates treatment for patients, such as individualized dosing, which can be used to treat particular disease states or patient groups. New approaches and techniques for creating unique medication delivery systems are made possible by the evolution of 3D techniques. The use of 3D printing technologies in the pharmaceutical industry is outlined in this paper, with special consideration devoted to the benefits of these technologies for attaining quick medication delivery, personalized drug delivery, compound drug delivery, and customizable drug delivery. This article also demonstrates the history, advantages, prospects, applications, constraints, and difficulties of 3D printing techniques in the area of developing pharmaceutical formulations. Pharmaceutical manufacturing is only one of many industries where the 3D printing (3DP) technique has had an important impact since its introduction in the early 1980s. Researchers and the public are becoming more interested in creating customized or individualized dosage forms as a result of the shifting horizons. The current work validates the viability of volumetric 3DP for quickly printing pharmaceutical items. This novel technology can enable the quick, on-demand manufacture of pharmaceuticals and medical equipment with further optimization.

If banana plant waste is not treated, it will be regarded as environmentally hazardous. Therefore, it is essential to find alternatives to incineration for the disposal of agricultural waste from banana plants. This waste can be converted into cellulose, which can be used for a variety of biological and pharmacological applications. Therefore, this study briefly outlined the numerous extraction methods that have been used so far on distinct banana plant components. As cellulose is also accompanied by hemicellulose and lignin along with fats, proteins, and pigments, all extraction techniques used the fundamental extraction stages, such as drying, alkaline treatment, bleaching, and washing with distilled water to achieve neutral pH, to remove this non-cellulosic matter. The cellulose that was produced would help reduce the overuse of synthetic, non-biodegradable materials. Therefore, the uses of cellulose are discussed, along with the potential biomedical uses of cellulose if it is converted to nanocrystalline cellulose.

Polycystic ovary syndrome (PCOS) is a complex endocrine disorder that significantly impacts reproductiveaged individuals globally. This paper explores recent breakthroughs in PCOS research that have revolutionized our understanding of its multifaceted nature. It delves into advancements in the understanding of etiology and pathophysiology through genetic research that has illuminated the genetic underpinnings of PCOS susceptibility. Insights into the intricate interplay of hormonal imbalances within PCOS and dysregulations in sex hormones, insulin, and other signaling molecules that contribute to PCOS symptomatology are discussed. A detailed examination of research into insulin resistance unveils its intricate connections with PCOS development, providing novel insights. The review emphasizes the role of personalized diagnostic and treatment approaches in harmonizing current research findings. It advocates for tailored strategies that consider each patient’s distinct presentation in recognition of PCOS heterogeneity. Ultimately, through a comprehensive assessment of contemporary PCOS research, this paper serves as a guiding light for clinicians and researchers and underscores the need for collaborative, evolving research to deliver targeted therapies.

Background: The study aimed to optimize and validate a nano-particulate technology for the sustained release of perindopril erbumine, an angiotensin-converting enzyme (ACE) inhibitor, using a box-behnken experimental methodology. Methods: The researcher used a Box-behnken experimental methodology to optimize the formulation and assess various characteristics such as particle size, zeta potential, surface shape, encapsulation efficiency and in vitro drug release. The nanoparticles characterization findings were recorded included the size, polydispersity index, zeta potential and encapsulation efficiency. Results: The nanoparticles had a smooth surface and their size was determined to be 122.38 ± 0.75 nm. The polydispersity index was 0.298, the zeta potential was 38.79 ± 0.05 mv and the encapsulation efficiency was 61.73 ± 0.06%. In vitro release was restricted for up to two hours, but at a pH of 7.4, the rate of drug release increased and was maintained. Conclusion: The study concluded that the nano-particulate technology for the potential to improve therapeutic efficacy and decrease dosage frequency for drug that need repeated doses such as perindopril erbumine.

Introduction: In the present study, the antibacterial activity against multidrug-resistant (MDR) Salmonella Typhimurium of different extracts of Five Medicinal Plants was investigated along with their phytochemical analysis by gas chromatography-mass spectrometry (GC-MS) and Molecular Docking Studies of Phytochemicals to explore antimicrobial compounds present in extracts. Materials and Methods: The antibacterial activities of different extracts of Five Medicinal Plants were evaluated against isolated MDR S. Typhimurium by disc diffusion method. Docking studies were carried out using different required docking platforms along with phytochemical analysis by GC-MS. Results and Discussion: The phytochemical analysis by quantitative and qualitative methods of the extract of Allium sativum, Bridelia micrantha, Citrus lemon, Glycyrrhiza glabra, and Punica granatum showed presence of amino acids, alkaloids, glycosides, saponins, flavonoids, steroids, and terpenoids. It was discovered that crude extracts of these plants worked well against MDR S. Typhimurium. The zone of inhibition values for the crude extract of A. sativum, B. micrantha, C. lemon, G. glabra, and P. granatum was found to be, 10.12 ± 1.71 mm, 23.50 ± 0.00 mm, 26.60 ± 0.64 mm, 29.20 ± 0.11 mm, and 19.50 ± 0.00 mm, respectively. Docking results of phyto-ligand with selected resistance genes proteins reveals that the binding energy ranges from −2.9 to −9.2 kcal/moL. G. glabra roots (Ligand 6-Androstanone, 3-(3, 4-dimethylphenyl)-3-methyl) showed the lowest binding energy of −9.2 kcal/moL. Conclusion: To produce broad-spectrum antimicrobial compounds, it is still important to assess the antibacterial potential of medicinal plants. Traditional medicine is one of the most generally available types of treatment in disadvantaged countries. According to the study’s findings, phytochemicals from five medicinal plants extract have in vitro antibacterial activity along with phyto-ligand docking analysis providing early evidence that the plants may be used to treat MDR infections.